(NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, recently announced findings from a real-world study ...

US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...

Over the past two decades, the scale-up of insecticide-treated nets, indoor residual spraying, rapid diagnostic testing, artemisinin-based combination therapy, seasonal malaria chemoprevention, ...

Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.

•Why disease still loses significant threatMalaria continues to pose a significant public health threat in Nigeria, remaining a perilous disease that affects millions annually. In this report, VINCENT ...

The Blue Earth City Council had a lot of things to approve at their meeting on Monday, April 20, with a bevy of new ordinances and resolutions being passed. Also on their agenda was a discussion about ...

Significant Progress in Malaria-Free Districts Representational Image Itanagar, April 26: In a remarkable achievement, ...

Tick season is off to an early and intense start across the U.S., with unusually high numbers of bites already reported.

Health experts warn that warmer temperatures and increased host populations could lead to higher disease transmission rates.

MeiraGTx closed an asset purchase with Janssen, a Johnson & Johnson company, on April 15, 2026, paying $25 million up front ...

Plus: Spy firms tap into a global telecom weakness to track targets, 500,000 UK health records go up for sale on Alibaba, ...

American drugmaker Regeneron's Otarmeni can restore natural hearing in children born deaf due to a genetic mutation ...